Stay updated on Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    A new revision label, v3.5.4, was added to the study documents and the previous label v3.5.3 was removed, indicating an updated documentation version in the record. This reflects an update to the study's protocol/documentation in the ClinicalTrials.gov record.
    Difference
    0.1%
    Check dated 2026-05-15T05:36:56.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    This change updates the site/revision version shown in the page footer from v3.5.2 to v3.5.3, indicating a minor release of the ClinicalTrials.gov page display.
    Difference
    0.1%
    Check dated 2026-04-24T06:28:59.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:43:47.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. This update appears to be an internal version change to the page.
    Difference
    0.1%
    Check dated 2026-03-19T06:01:17.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:16:18.000Z thumbnail image
  9. Check
    113 days ago
    Change Detected
    Summary
    A new site Revision: v3.4.2 appears, and the previous government funding notice (and Revision: v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:33:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page.